Tekla Life Sciences Investors (HQL) Position Lifted by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC increased its position in shares of Tekla Life Sciences Investors (NYSE:HQL) by 7.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 248,074 shares of the company’s stock after acquiring an additional 16,842 shares during the quarter. Tekla Life Sciences Investors comprises 0.9% of Flagship Harbor Advisors LLC’s holdings, making the stock its 11th biggest position. Flagship Harbor Advisors LLC owned 1.13% of Tekla Life Sciences Investors worth $4,661,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQL. Quad Cities Investment Group LLC acquired a new position in Tekla Life Sciences Investors during the 1st quarter valued at approximately $233,000. Private Advisor Group LLC acquired a new position in Tekla Life Sciences Investors during the 1st quarter valued at approximately $418,000. Stephens Inc. AR increased its stake in Tekla Life Sciences Investors by 80.3% during the 1st quarter. Stephens Inc. AR now owns 23,301 shares of the company’s stock valued at $448,000 after purchasing an additional 10,375 shares in the last quarter. NINE MASTS CAPITAL Ltd acquired a new position in Tekla Life Sciences Investors during the 2nd quarter valued at approximately $456,000. Finally, Stifel Financial Corp increased its stake in Tekla Life Sciences Investors by 70.5% during the 1st quarter. Stifel Financial Corp now owns 27,849 shares of the company’s stock valued at $533,000 after purchasing an additional 11,512 shares in the last quarter. Hedge funds and other institutional investors own 14.28% of the company’s stock.

Shares of Tekla Life Sciences Investors stock opened at $19.67 on Monday. Tekla Life Sciences Investors has a 12-month low of $18.01 and a 12-month high of $22.24.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Tuesday, August 28th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, August 27th. This represents a $1.60 dividend on an annualized basis and a yield of 8.13%.

About Tekla Life Sciences Investors

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.

Read More: Marijuana Stocks Investing Considerations

Want to see what other hedge funds are holding HQL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tekla Life Sciences Investors (NYSE:HQL).

Institutional Ownership by Quarter for Tekla Life Sciences Investors (NYSE:HQL)

Receive News & Ratings for Tekla Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply